220 related articles for article (PubMed ID: 32773781)
1. Demographics and coexisting tremor, cervical dystonia and vocal fold disorders in a group of patients with spasmodic dysphonia.
Karatayli Ozgursoy S; Vargas ER; Heckman MG; Rutt AL
Acta Otorhinolaryngol Ital; 2020 Jun; 40(3):198-203. PubMed ID: 32773781
[TBL] [Abstract][Full Text] [Related]
2. Case-control study of risk factors for spasmodic dysphonia: A comparison with other voice disorders.
Tanner K; Roy N; Merrill RM; Sauder C; Houtz DR; Smith ME
Laryngoscope; 2012 May; 122(5):1082-92. PubMed ID: 22253036
[TBL] [Abstract][Full Text] [Related]
3. The Mayo Clinic Arizona Spasmodic Dysphonia Experience: A Demographic Analysis of 718 Patients.
Patel AB; Bansberg SF; Adler CH; Lott DG; Crujido L
Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):859-63. PubMed ID: 26024910
[TBL] [Abstract][Full Text] [Related]
4. Sulcus vocalis in spasmodic dysphonia-A retrospective study.
Nerurkar NK; Agrawal D; Joshi D
Am J Otolaryngol; 2021; 42(3):102940. PubMed ID: 33545449
[TBL] [Abstract][Full Text] [Related]
5. Validation of a telephone screening tool for spasmodic dysphonia and vocal fold tremor.
Johnson DM; Hapner ER; Klein AM; Pethan M; Johns MM
J Voice; 2014 Nov; 28(6):711-5. PubMed ID: 24962230
[TBL] [Abstract][Full Text] [Related]
6. The effect of unilateral thalamic deep brain stimulation on the vocal dysfunction in a patient with spasmodic dysphonia: interrogating cerebellar and pallidal neural circuits.
Poologaindran A; Ivanishvili Z; Morrison MD; Rammage LA; Sandhu MK; Polyhronopoulos NE; Honey CR
J Neurosurg; 2018 Feb; 128(2):575-582. PubMed ID: 28304188
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and demographics in patients with spasmodic dysphonia.
Schweinfurth JM; Billante M; Courey MS
Laryngoscope; 2002 Feb; 112(2):220-3. PubMed ID: 11889373
[TBL] [Abstract][Full Text] [Related]
8. Coprevalence of tremor with spasmodic dysphonia: a case-control study.
White LJ; Klein AM; Hapner ER; Delgaudio JM; Hanfelt JJ; Jinnah HA; Johns MM
Laryngoscope; 2011 Aug; 121(8):1752-5. PubMed ID: 21792965
[TBL] [Abstract][Full Text] [Related]
9. Findings of multiple muscle involvement in a study of 214 patients with laryngeal dystonia using fine-wire electromyography.
Klotz DA; Maronian NC; Waugh PF; Shahinfar A; Robinson L; Hillel AD
Ann Otol Rhinol Laryngol; 2004 Aug; 113(8):602-12. PubMed ID: 15330138
[TBL] [Abstract][Full Text] [Related]
10. Consensus-Based Attributes for Identifying Patients With Spasmodic Dysphonia and Other Voice Disorders.
Ludlow CL; Domangue R; Sharma D; Jinnah HA; Perlmutter JS; Berke G; Sapienza C; Smith ME; Blumin JH; Kalata CE; Blindauer K; Johns M; Hapner E; Harmon A; Paniello R; Adler CH; Crujido L; Lott DG; Bansberg SF; Barone N; Drulia T; Stebbins G
JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):657-665. PubMed ID: 29931028
[TBL] [Abstract][Full Text] [Related]
11. Neurologic aspects of spasmodic dysphonia.
Rosenfield DB; Donovan DT; Sulek M; Viswanath NS; Inbody GP; Nudelman HB
J Otolaryngol; 1990 Aug; 19(4):231-6. PubMed ID: 2213994
[TBL] [Abstract][Full Text] [Related]
12. Vibratory Onset of Adductor Spasmodic Dysphonia and Muscle Tension Dysphonia: A High-Speed Video Study✰.
Chen W; Woo P; Murry T
J Voice; 2020 Jul; 34(4):598-603. PubMed ID: 30595236
[TBL] [Abstract][Full Text] [Related]
13. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges.
Barkmeier JM; Case JL; Ludlow CL
J Commun Disord; 2001; 34(1-2):21-37. PubMed ID: 11322567
[TBL] [Abstract][Full Text] [Related]
14. Tremor Makes a Difference: A Comparative Study of the Demographics and Treatment Outcomes in Patients With Adductor Spasmodic Dysphonia With or Without Vocal Tremor.
Heyes R; Adler C; Zhang N; Abdel-Aty Y; Lott DG; Bansberg SF
J Voice; 2024 Feb; ():. PubMed ID: 38378346
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid Use in the Treatment of Laryngeal Dystonia and Vocal Tremor: A Pilot Investigation.
Millman N; van der Woerd B; Sund LT; Johns M
J Voice; 2023 Jun; ():. PubMed ID: 37308367
[TBL] [Abstract][Full Text] [Related]
16. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
Kendall KA; Leonard RJ
J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
[TBL] [Abstract][Full Text] [Related]
17. A separation of innate and learned vocal behaviors defines the symptomatology of spasmodic dysphonia.
Guiry S; Worthley A; Simonyan K
Laryngoscope; 2019 Jul; 129(7):1627-1633. PubMed ID: 30582159
[TBL] [Abstract][Full Text] [Related]
18. Head tremor at disease onset: an ataxic phenotype of cervical dystonia.
Merola A; Dwivedi AK; Shaikh AG; Tareen TK; Da Prat GA; Kauffman MA; Hampf J; Mahajan A; Marsili L; Jankovic J; Comella CL; Berman BD; Perlmutter JS; Jinnah HA; Espay AJ
J Neurol; 2019 Aug; 266(8):1844-1851. PubMed ID: 31028543
[TBL] [Abstract][Full Text] [Related]
19. Reliability of High-speed Videoendoscopic Ratings of Essential Voice Tremor and Adductor Spasmodic Dysphonia.
Parker LA; Kunduk M; Fink DS; McWhorter A
J Voice; 2019 Jan; 33(1):16-26. PubMed ID: 29246397
[TBL] [Abstract][Full Text] [Related]
20. Neuropathology of spasmodic dysphonia.
Schaefer SD
Laryngoscope; 1983 Sep; 93(9):1183-204. PubMed ID: 6136880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
